Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial. - Wikidata - awgldk - TriplyDB

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

http://www.wikidata.org/entity/Q37221225

about

Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.

P2860

Q35750717-80EA7832-36BD-4EC0-9C98-1C29ADC8F1E5

P2860

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

http://www.wikidata.org/entity/Q37221225

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@en

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@nl

type

label

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@en

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@nl

prefLabel

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@en

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@nl

P1433

Q37221225-BD3FE84A-49D6-4D95-B8FE-EC7FB1B641A6

P1476

Q37221225-A824D744-360F-4AA7-90BC-22A0EAA63D26

P2093

Q37221225-340D17C9-4AC8-4A20-B2E0-60409FAA95A9

Q37221225-5C3276BF-2616-4D2A-8386-24E72ECB7FBE

Q37221225-9EE89AB7-C805-484E-8FF3-6D9A4F691A3A

Q37221225-BC72C213-3D10-4644-9604-A5E1C314EA79

Q37221225-F52B5E2C-A50E-4D09-820A-9A2184341DFD

P2860

Q37221225-01149626-135D-4FAF-AD50-94E63EBEA440

Q37221225-04D29345-E965-42F3-92E2-1E849E1162C8

Q37221225-059C2E9F-3072-4A1D-9E58-EEBEB90739F5

Q37221225-0A10303F-97A8-4559-989E-B120AEC0C498

Q37221225-0C2D1D5F-9C03-4BC5-A8B1-DC5EA80BFAAA

Q37221225-0CA19A4B-6051-4620-AD08-2CF44F2DAF1D

Q37221225-1756DE0C-7E07-431F-A20B-F5ECB9E14483

Q37221225-1CE9AAE4-C716-47BD-BD94-E5502855133A

Q37221225-1D218A2D-F57C-4531-A047-6496FC8A4A8D

Q37221225-253E9200-A6B2-4547-9AAA-ADF50D051B8E

P304

Q37221225-4BA03E15-D5BA-421D-91D3-E63FA45987F8

P31

Q37221225-3B746D14-F2E9-4CEF-86B7-D3832A8741C6

P356

Q37221225-02E867B0-E393-476E-8155-0D81BC95FCC5

P407

Q37221225-D948ED41-96EA-4E9A-9926-6BC95C32052A

P478

Q37221225-1AEDC015-A297-401D-8DCC-8FD69BB961A1

P577

Q37221225-0D504250-DBEF-4CFD-B7FF-D331CF5E026F

P698

Q37221225-3C706B9C-A9DE-46A4-A436-5DBEBEDC3AC1

P932

Q37221225-9BEADF55-742B-41C0-A975-F76771DFD124

P356

P1433

Vascular Health and Risk Management

P1476

Comparative effectiveness of a ...... ts of the 6-month ELIZA trial.

@en

P2093

A S Dobrokhod

http://www.w3.org/2001/XMLSchema#string

G D Radchenko

http://www.w3.org/2001/XMLSchema#string

O O Torbas

http://www.w3.org/2001/XMLSchema#string

S M Kushnir

http://www.w3.org/2001/XMLSchema#string

Y M Sirenko

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?

Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol

Beta-blockers continue to surprise us.

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients.

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients.

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement.

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

P304

535-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S44568

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24109189

http://www.w3.org/2001/XMLSchema#string

P932

3792946

http://www.w3.org/2001/XMLSchema#string